Fidel Chaves | Stämm

Bio-Inspired Industrial Design: Sustainable Innovation

The Problem In today’s industrialized world, the design and production processes often clash with sustainability principles and ecological balance. Traditional industrial design focuses on assembling homogeneous parts, emphasizing efficiency, maximum growth, and profit. This culture of parts operates in straight lines, ignoring the dynamic and heterogeneous nature of biological systems. The challenge lies in creating … Bio-Inspired Industrial Design: Sustainable Innovation

Full Agile Science

The Need for Change Research projects are fundamental to scientific advancement, ranging from individual theses to large-scale international collaborations. The thing is, many of the procedures and methods in use date from an era unlike our own. Traditional methods have been useful for many years. However, they can sometimes be costly, time-consuming, and hinder quick … Full Agile Science

Model in the Machine: Computational Fluid Dynamics

Introduction: What’s Computational Fluid Dynamics? Computational Fluid Dynamics (CFD) is a field that incorporates numerical analysis to simulate and solve problems involving fluid flows. It’s an iterative process that requires a lot of computational process. Even if analytical and experimental options exist, we use computers to solve fluid dynamics. Simplifying the differences between methods: Analytical: … Model in the Machine: Computational Fluid Dynamics

What is Biomimicry? The Train and the Kingfisher

Japanese engineers, faced with a sonic dilemma in their high-speed trains, turned to the Kingfisher for a solution. Last century, Japan encountered a predicament with its iconic Shinkansen bullet trains. Exceeding speeds of 200 miles per hour triggered a disruptive sound when passing through a tunnel. The resulting challenge, known as the tunnel boom, arose … What is Biomimicry? The Train and the Kingfisher

Towards Universal iPSCs: Stämms Take on Autologous Therapies

Autologous therapies, installed capacity, and lab automation: three key concepts we discussed on the latest Swiss Biotech Day. Learn how Stämm participated at the premier biotechnology conference in Europe, talking through the latest in iPSCs-based therapies. The Swiss Biotech Day experience Juan Martin Cabaleiro, Román Ortega Bianchi, and Sebastián de Achaval attended the latest Swiss … Towards Universal iPSCs: Stämms Take on Autologous Therapies

Scaling Up Biomanufacturing: Overcoming Challenges and Driving Innovation

In the landscape of healthcare and pharmaceuticals, scaling up biomanufacturing processes is both a challenge and a crucial endeavor. Industry professionals, researchers, and investors understand how biomanufacturing provides life-saving therapeutics to the market. Nowadays, we have to navigate industry and R&D challenges while uncovering opportunities for innovation. The Challenge of Scaling Up Scaling up industrial … Scaling Up Biomanufacturing: Overcoming Challenges and Driving Innovation

What Fueled Stämm’s Success in Switzerland?

If you read the first article of this newsletter, or you’ve been keeping up with our Linkedin posts, then you probably know that last year our team embarked on a scientific journey. The Bioprocessor, our flagship product, traveled to Switzerland for two months to be demoed by partners outside Stämm. We conducted multiple runs at … What Fueled Stämm’s Success in Switzerland?

Stämm’s Successful Venture at JP Morgan Week: Building Alliances and Sharing Biotech Innovations

From 8 to 11 January, we participated in the JP Morgan Week in San Francisco, where the top players in the biotech industry meet. At the same time, we attended the Biotech Showcase, where we had one-on-one talks with key players. In addition to Yuyo Llamazares Vegh, our co-founder and CEO, our team included Juan … Stämm’s Successful Venture at JP Morgan Week: Building Alliances and Sharing Biotech Innovations

Testing